The Pharmacy Times® 503B Compounding Pharmacy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to compounding pharmacies and drug safety.
November 1st 2024
Martha Rumore, PharmD, Esq, discusses the legal and regulatory complexities surrounding tirzepatide compounding following FDA’s removal of the drug from the shortage list, which prompted a lawsuit and led to ongoing uncertainty for 503A and 503B facilities regarding enforcement discretion and future compounding restrictions.
Challenges and Innovations in the Manufacture of Hazardous Drugs
January 11th 2019USP General Chapter , which was published by the United States Pharmacopeial Convention and updated most recently in December 2017, sets forth guidelines for the handling of hazardous drugs in the health care setting with the goal of promoting safety for patients and health care workers.
Read More
The Challenges of USP 800 for Compounding Pharmacies
November 8th 2018In this clip, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for University at Buffalo's patient safety organization Empire State Patient Safety Assurance Network, explains the challenges compounding pharmacies will face with USP800.
Watch
USP 800: Performing an Assessment of Risk for Hazardous Drug Handling
August 8th 2018In this clip, Patricia Kienle, BSPharm, MPA, FASHP, Director of Accreditation and Medication Safety at Cardinal Health Innovative Delivery Solutions, discusses key steps for performing an assessment of risk in compliance with USP 800.
Watch
Pharmacist-Physician Collaborations Shown to be Mutually Beneficial
June 11th 2018At the American Pharmacy Purchasing Alliance’s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work.
Read More